Some Prostate Cancer Patients Might Safely Delay Hormonal Therapy
Even if PSA levels are rising, postponing the treatment may boost quality of life without lowering survival Source: HealthDay Related MedlinePlus Page: Prostate Cancer (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - May 14, 2014 Category: Consumer Health News Source Type: news

“A Study on Prostate Cancer Relapses Suggests that Hormone Therapy Can Wait,”
This article features commentary from physicians at Dana-Farber/Brigham and Women’s Cancer Center and Moffitt Cancer Center-two of the 25 NCCN Member Institutions. ... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - May 14, 2014 Category: Cancer & Oncology Source Type: news

Early menopause linked to mental decline
Conclusion This study found a link between premature menopause and memory problems. Strengths of the study include the large number of participants and the fact they were followed prospectively, which reduces the chance of bias. However, as it was a cohort study, it cannot prove that the memory problems were caused by their premature menopause. The researchers analysed the results, taking multiple factors into consideration. Patient recall, the age of menopause and the type and duration of taking any hormonal therapy may also have been inaccurate. A further limiting factor in this study is that it commenced when women were...
Source: NHS News Feed - May 8, 2014 Category: Consumer Health News Tags: Neurology Lifestyle/exercise Cancer Source Type: news

Combined hormone therapy clinical trial yields massive economic return
The overall economic return from a combined hormone therapy clinical trial indicates that changes in practice stemming from the trial provided a net economic return of $37.1 billion over the 10-year period since the main findings were published. "The motivation for the first WHI trial was to see if we could prevent heart disease, the number one killer of women. That's why we did it -- the economics never occurred to me," said the lead investigator. What these findings underscore is the significant role clinical trials play in science and the importance of continuing to find ways to strategically invest public res...
Source: ScienceDaily Headlines - May 6, 2014 Category: Science Source Type: news

WHI reports $37.1B economic return on combined hormone therapy clinical trial
(Fred Hutchinson Cancer Research Center) The overall economic return from the Women's Health Initiative E+P trial indicates that changes in practice stemming from the trial provided a net economic return of $37.1 billion over the 10-year period since the main findings were published. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 5, 2014 Category: Cancer & Oncology Source Type: news

WHI reports $37.1 billion economic return on combined hormone therapy clinical trial
(Fred Hutchinson Cancer Research Center) The overall economic return from the Women's Health Initiative E+P trial indicates that changes in practice stemming from the trial provided a net economic return of $37.1 billion over the 10-year period since the main findings were published. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 5, 2014 Category: Cancer & Oncology Source Type: news

HRT Treatments / Diet Doc Hormone Replacement & Weight Loss Plans...
Diet Doc now offers patients a great new way to test for hormonal imbalance that may be causing weight gain, or hindering weight loss, with new Weight Management Profile hormone testing kits, done...(PRWeb April 25, 2014)Read the full story at http://www.prweb.com/releases/hormone-therapy/weight-loss/prweb11795003.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 26, 2014 Category: Pharmaceuticals Source Type: news

HRT Treatments / Diet Doc Hormone Therapy & Weight Loss Plans...
Diet Doc now offers hormone replacement therapy, utilizing bio-identical hormones to relieve symptoms of hormonal imbalance. Test kits are sent directly to the patient’s home, and results are...(PRWeb April 19, 2014)Read the full story at http://www.prweb.com/releases/hormone-replacement/hormonal-imbalance/prweb11777897.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 19, 2014 Category: Pharmaceuticals Source Type: news

Six months hormone therapy in addition to radiotherapy improves prostate cancer survival (Medical Xpress, 7 April 2014)
A French study presented at the 33rd conference of the European Society for Radiotherapy and Oncology in Vienna assessed prostate cancer survival rates for men undergoing radiotherapy combined with androgen deprivation therapy. Full article (Source: Society for Endocrinology)
Source: Society for Endocrinology - April 8, 2014 Category: Endocrinology Source Type: news

Hormone therapy linked to lower non-Hodgkin lymphoma risk
Menopausal hormone therapy use is linked to a lower risk of B-cell non-Hodgkin lymphoma, research has found. "The connection between lymphomas and menopausal hormone therapy use hinges on understanding the disease's biology and the window of susceptibility," the lead researcher said. "Hormone therapy is of interest because the loss of estrogen coupled with aging in women result in decreased immune function, which can elevate risk of non-Hodgkin lymphoma." (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 7, 2014 Category: Science Source Type: news

Six months hormone therapy in addition to radiotherapy improves prostate cancer survival
(European Society for Radiotherapy and Oncology (ESTRO)) Men with prostate cancer that is small and confined to the prostate gland but that is at risk of growing and spreading, do better if they are treated with radiotherapy combined with androgen deprivation therapy, which lowers their levels of the male hormone, testosterone, according to new research to be presented at the 33rd conference of the European Society for Radiotherapy and Oncology in Vienna. The findings are expected to change clinical practice. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 6, 2014 Category: Cancer & Oncology Source Type: news

Intimacy and Sex After Cancer Treatment is Over
Intimacy and sex after cancer treatment is over Emotions can have a strong effect on your desire for sex due to anxiety, fears and physical changes during and after cancer treatment. Be patient as you heal. Hormone therapy for breast cancer Get the facts about this treatment for breast cancers that are sensitive to hormones. [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - March 24, 2014 Category: Databases & Libraries Source Type: news

Some Breast Cancers Require Longer Tx
(MedPage Today) -- Breast cancers with high-level estrogen sensitivity had a significantly greater risk of late recurrence, possibly indicating a need for more than 5 years of adjuvant hormonal therapy, British investigators reported. (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - March 21, 2014 Category: Primary Care Source Type: news

Extended hormone therapy may help some women with ER+ breast cancer
Genetic analyses of results from 1125 postmenopausal women being treated for oestrogen responsive breast cancer have shown that some of them are more likely than others to have a late recurrence of their cancer and might benefit from ten years of hormone therapy rather than five. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - March 21, 2014 Category: Consumer Health News Tags: Breast Cancer Source Type: news

Menopause hormone therapy: Pros and cons
(Source: MayoClinic.com Full Feed)
Source: MayoClinic.com Full Feed - March 21, 2014 Category: Consumer Health News Source Type: news

Genetic testing may help select women with ER+ breast cancer for extended hormone therapy
(ECCO-the European CanCer Organisation) Genetic analyses of results from 1125 postmenopausal women being treated for oestrogen responsive breast cancer have shown that some of them are more likely than others to have a late recurrence of their cancer and might benefit from ten years of hormone therapy rather than five. The research is presented at the European Breast Cancer Conference in Glasgow. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 19, 2014 Category: Global & Universal Source Type: news

Finding the Cure for Age in One Injection
Looking for the Elixir of Youth--in One Shotread more (Source: Psychology Today Sex Center)
Source: Psychology Today Sex Center - March 19, 2014 Category: Sexual Medicine Authors: Randi Hutter Epstein, M.D. Tags: Health Sex hormone therapy rejuvenation testosterone therapy Source Type: news

In postmenopausal women at risk for dementia, estradiol preserves key brain regions
When initiated soon after menopause, hormone therapy with estradiol prevented degeneration in key brain regions of women who were at heightened dementia risk, according to a new study led by Stanford University School of Medicine researchers.The investigators also found that another type of hormone therapy, marketed under the brand name Premarin, was far less protective. Premarin is a mixture of 30-plus substances derived from the urine of pregnant mares. Estradiol - the dominant sex-steroid hormone in woman - accounts for about 17 percent of Premarin's total content. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - March 14, 2014 Category: Consumer Health News Tags: Alzheimer's / Dementia Source Type: news

Better survival after lung cancer diagnosis in women linked to hormone therapy
Survival among people with lung cancer has been better for women than men, and the findings of a recent study indicate that female hormones may be a factor in this difference. The combination of estrogen plus progesterone and the use of long-term hormone therapy were associated with the most significant improvements in survival.The study was designed to explore the influence of several reproductive and hormonal factors on overall survival of women with non-small cell lung cancer (NSCLC). (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - February 28, 2014 Category: Consumer Health News Tags: Lung Cancer Source Type: news

UCLA study finds robotic-assisted prostate surgery offers better cancer control
An observational study from UCLA's Jonsson Comprehensive Cancer Center has found that prostate cancer patients who undergo robotic-assisted prostate surgery have fewer instances of cancer cells at the edge of their surgical specimen and less need for additional cancer treatments like hormone or radiation therapy than patients who have traditional "open" surgery.   The study, published online Feb. 19 in the journal European Urology, was led by Dr. Jim Hu, UCLA's Henry E. Singleton Professor of Urology and director of robotic and minimally invasive surgery in the urology department at the David Geffen School o...
Source: UCLA Newsroom: Health Sciences - February 28, 2014 Category: Universities & Medical Training Source Type: news

Hormone therapy linked to better survival after lung cancer diagnosis in women
Survival among people with lung cancer has been better for women than men, and the findings of a recent study indicate that female hormones may be a factor in this difference. The combination of estrogen plus progesterone and the use of long-term hormone therapy were associated with the most significant improvements in survival. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 26, 2014 Category: Science Source Type: news

Hormone therapy linked to better survival after lung cancer diagnosis in women
(International Association for the Study of Lung Cancer) Survival among people with lung cancer has been better for women than men, and the findings of a recent study indicate that female hormones may be a factor in this difference. The combination of estrogen plus progesterone and the use of long-term hormone therapy were associated with the most significant improvements in survival. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 26, 2014 Category: Cancer & Oncology Source Type: news

Moderate Exercise Cuts Women's Stroke Risk, Helps Offset Increase Risk from Hormone Therapy
Source: American Heart Association Related MedlinePlus Pages: Hormone Replacement Therapy, Stroke (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - February 14, 2014 Category: Consumer Health News Source Type: news

Exercise Cuts Stroke Risk From Hormone Therapy (CME/CE)
(MedPage Today) -- Exercise may moderately shave off some of the increased risk of hormone therapy, researchers found. (Source: MedPage Today OB/GYN)
Source: MedPage Today OB/GYN - February 13, 2014 Category: OBGYN Source Type: news

Prostate cancer advance could improve treatment options
Researchers have made an important advance in understanding genetic changes associated with terminal prostate cancer. The research highlights why relapses could happen in some men following hormone therapy. And it could help identify those patients that will develop fatal prostate cancer much earlier for life-extending therapy. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 12, 2014 Category: Science Source Type: news

Prostate cancer advance could improve treatment options
(University of East Anglia) Researchers at the University of East Anglia have made an important advance in understanding genetic changes associated with terminal prostate cancer. The research highlights why relapses could happen in some men following hormone therapy. And it could help identify those patients that will develop fatal prostate cancer much earlier for life-extending therapy. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - February 12, 2014 Category: Biology Source Type: news

Researchers discover new hormone receptors to target when treating breast cancer
(Brigham and Women's Hospital) The findings offer the possibility of expanding the ways patients with breast cancer are treated with hormone therapy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 4, 2014 Category: Cancer & Oncology Source Type: news

More than one-third of women have hot flashes 10 years after menopause
A team of researchers has found that moderate to severe hot flashes continue, on average, for nearly five years after menopause, and more than a third of women experience moderate/severe hot flashes for 10 years or more after menopause. Current guidelines recommend that hormone therapy, the primary medical treatment for hot flashes, not continue for more than 5 years. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - January 30, 2014 Category: Science Source Type: news

Postmenopausal Hormone Therapy Linked to Acute Pancreatitis (FREE)
By Amy Orciari Herman Postmenopausal women who use systemic hormone therapy face increased risk for acute pancreatitis, according to a prospective study in the Canadian Medical Association Journal.Over 31,000 postmenopausal women in … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - January 28, 2014 Category: Primary Care Source Type: news

Hormone Therapy May Cut Risk of Repeat Joint Replacement Surgery in Women
Title: Hormone Therapy May Cut Risk of Repeat Joint Replacement Surgery in WomenCategory: Health NewsCreated: 1/23/2014 12:35:00 PMLast Editorial Review: 1/24/2014 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - January 24, 2014 Category: Rheumatology Source Type: news

What Evaluation Should Be Considered for Heavy Menstrual Bleeding?
Discussion Heavy menstrual bleeding is a common problem. The rates depend on the population and underlying cause, but can occur 30% of adolescent females who go to a gynecologist. Average menstrual blood loss is 30-40 ml. Hypermenorrhea or menorrhagia are regular menstrual cycles that last too long (>7 days) or are too heavy (> 80 ml blood loss). Metrorrhagia is irregular menstrual bleeding. Menometrorrhagia is abnormally heavy bleeding that occurs with an irregular timing. Dysfunctional uterine bleeding is a more generic term describing prolonged, excessive or frequent, unpatterned uterine bleeding that is not relat...
Source: PediatricEducation.org - January 20, 2014 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Osteoporosis and Hormone Therapy for Prostate...
Osteoporosis is associated with hormone therapy for prostate cancer. Learn more. (Source: About.com Prostate Cancer)
Source: About.com Prostate Cancer - January 14, 2014 Category: Cancer & Oncology Tags: health Source Type: news

Alan Turing's pardon is wrong | Ally Fogg
To single out Turing is to say all the other persecuted gay men are not so deserving of justice because they were less exceptionalThe Queen's announcement of a posthumous pardon, under a Royal Prerogative of Mercy, to Alan Turing follows a long campaign and a petition signed by more than 37,000 people. The pardon will be welcomed by many, and it is undoubtedly a gesture of humanity, compassion and progressive values. It is also entirely, profoundly wrong.Turing was an intellectual legend of the 20th century. His breakthroughs in applied mathematics have led him to be described as the father of modern computing. His work on...
Source: Guardian Unlimited Science - December 24, 2013 Category: Science Authors: Ally Fogg Tags: Comment Alan Turing theguardian.com Sexuality World news Gay rights Law Politics UK news Second world war Human rights Science Comment is free Source Type: news

Leukemia Drug Boosts Endocrine Breast Tx (CME/CE)
SAN ANTONIO (MedPage Today) -- The leukemia drug dasatinib (Sprycel) doubled time to disease progression or death for women starting hormonal therapy for metastatic breast cancer but failed to affect clinical response, an early-phase trial showed. (Source: MedPage Today OB/GYN)
Source: MedPage Today OB/GYN - December 13, 2013 Category: OBGYN Source Type: news

Exercise Linked to Lower Breast Cancer Risk in Black Women
Regular, brisk activity seems to help prevent some aggressive tumors that resist hormone therapy, study says (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - December 12, 2013 Category: Cancer & Oncology Authors: webmaster at doctorslounge.com Tags: Gynecology, Oncology, Research, Sports Medicine, News, Source Type: news

Exercise Linked to Lower Breast Cancer Risk in Black Women
Regular, brisk activity seems to help prevent some aggressive tumors that resist hormone therapy, study says Source: HealthDay Related MedlinePlus Pages: African American Health, Breast Cancer, Exercise and Physical Fitness (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - December 12, 2013 Category: Consumer Health News Source Type: news

Some older patients with breast cancer may avoid radiotherapy
Omission of radiotherapy is a reasonable option for women age 65 or older who receive hormone therapy after breast-conserving surgery for hormone receptor-positive, axillary node-negative breast cancer, according to results of the PRIME 2 trial presented at the 2013 San Antonio Breast Cancer Symposium, held Dec. 10-14."Radiotherapy has been known to reduce the risk of breast cancer recurrence three- to fourfold. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 12, 2013 Category: Consumer Health News Tags: Breast Cancer Source Type: news

Avoiding radiotherapy is an option for some older patients with breast cancer
(American Association for Cancer Research) Omission of radiotherapy is a reasonable option for women age 65 or older who receive hormone therapy after breast-conserving surgery for hormone receptor-positive, axillary node-negative breast cancer, according to results of the PRIME 2 trial presented here at the 2013 San Antonio Breast Cancer Symposium, held Dec. 10-14. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 11, 2013 Category: Cancer & Oncology Source Type: news

sCD163 and sex steroids
Soluble CD163 (sCD163) is linked to low-grade inflammation states, including diabetes, obesity, liver disease, and atherosclerosis, all of which are prevalent in Turner Syndrome (TS) and Klinefelter Syndrome (KS). Thomsen and colleagues assessed the levels and regulation of sCD163 with regard to treatment with sex hormone therapy in males with KS and females with TS. They found that males with KS had higher levels of sCD163 compared with controls and the levels correlated to plasma testosterone. Treatment with testosterone did not significantly lower sCD163. Females with TS not receiving hormone replacement therapy (HRT) h...
Source: Society for Endocrinology - December 10, 2013 Category: Endocrinology Source Type: news

NIH-Funded Study Shows Increased Survival in Men with Metastatic Prostate Cancer Who Receive Chemotherapy When Starting Hormone Therapy
Source: National Cancer Institute - Related MedlinePlus Page: Prostate Cancer (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - December 6, 2013 Category: Consumer Health News Source Type: news

What's a Normal Lab Result for a Transgender Patient?What's a Normal Lab Result for a Transgender Patient?
Transgender patients on hormone therapy should have their own laboratory reference ranges, researchers say. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 14, 2013 Category: Consumer Health News Tags: Family Medicine/Primary Care News Source Type: news

Presence of hot flashes may predict success of hormone therapy
Hormones at menopause can help with sleep, memory, and more, but only when a woman also has hot flashes, find researchers at Helsinki University in Finland. Their study was published online in Menopause, the journal of The North American Menopause Society (NAMS).NAMS and 14 other leading women's health organizations agree that hormone therapy is acceptable at menopause for most women who are bothered by moderate to severe menopause symptoms. For women who aren't bothered by moderate to severe hot flashes, this study indicates that hormone therapy will not improve their quality of life. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 14, 2013 Category: Consumer Health News Tags: Menopause Source Type: news

Hormone Therapy May Work Only for Women With Hot Flashes
Study finds gains in memory, sleep and focus aren't universal (Source: WebMD Health)
Source: WebMD Health - November 13, 2013 Category: Consumer Health News Source Type: news

Hormone Therapy May Work Only for Women With Hot Flashes
Title: Hormone Therapy May Work Only for Women With Hot FlashesCategory: Health NewsCreated: 11/13/2013 9:35:00 AMLast Editorial Review: 11/13/2013 12:00:00 AM (Source: MedicineNet Menopause General)
Source: MedicineNet Menopause General - November 13, 2013 Category: Primary Care Source Type: news

Hormonal Therapy Possible for Some Uterine Cancer CasesHormonal Therapy Possible for Some Uterine Cancer Cases
Dr. Kovacs reviews the options available for women wishing to preserve their fertility after treatment. Medscape Ob/Gyn (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 12, 2013 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Viewpoint Source Type: news

Prostate cancer deaths fall by a fifth in 20 years, says Cancer Research UK
Prostate cancer is second most common cause of cancer death among men, but progress has been made in treatmentDeath rates from prostate cancer have fallen by a fifth in the last two decades, according to Cancer Research UK.Prostate cancer is the second most common cause of cancer death among men and the fourth overall. But, the charity says, considerable progress has been made in life-saving treatment.Better treatment, more widespread use of hormone therapy, radical surgery and radiotherapy have all played a part in the drop in death rate.In the early 1990s, there were around 30 deaths per 100,000 men in the population, bu...
Source: Guardian Unlimited Science - November 1, 2013 Category: Science Authors: Sarah Boseley Tags: The Guardian News Health Medical research Society Cancer UK news Prostate cancer Source Type: news

Developing world faces breast cancer surge, study suggests
Rising breast cancer incidence and mortality represent a significant and growing threat for the developing world, according to a new global study commissioned by GE Healthcare. Explained report co-author Bengt Jönsson, Professor in Health Economics at the Stockholm School of Economics: "Breast cancer is on the rise across developing nations, mainly due to the increase in life expectancy and lifestyle changes such as women having fewer children, as well as hormonal intervention such as post-menopausal hormonal therapy... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 18, 2013 Category: Consumer Health News Tags: Breast Cancer Source Type: news

Take-Home Points From the WHI Hormone Therapy TrialsTake-Home Points From the WHI Hormone Therapy Trials
How should findings from the latest Women's Health Initiative trials inform your clinical decision-making? Dr. JoAnn Manson explains. Medscape Ob/Gyn (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 8, 2013 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Commentary Source Type: news

The last word on hormone therapy?
When Janice hit menopause, she had terrible night sweats and hot flashes, but she was scared to undergo hormone replacement therapy. (Source: WDSU.com - Health)
Source: WDSU.com - Health - October 2, 2013 Category: Consumer Health News Source Type: news

Hormone replacement therapy may not help against heart disease, but can provide benefits
Estrogen/progestin combination hormone therapy raised breast cancer risk and didn't reduce heart disease; estrogen-only had fewer risks for younger women (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - October 2, 2013 Category: Consumer Health News Source Type: news